Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Trading Update

23 Jul 2009 07:00

RNS Number : 1435W
TyraTech, Inc.
23 July 2009
 



For immediate release

23 July 2009

There will be a conference call for investors and analysts to discuss this announcement today at 11:00 (BST). Dial-in details are as follows: UK Access Number: +44 (0)20 8609 1435, US toll free number: 1866 793 4279, PIN code: 356088#. A replay of the conference call will be available for one month via UK: 0800 358 2189 or 020 8609 0289, US: 1 866 676 5865. Conference reference number: 268811#.

TYRATECH, INC.

("TyraTech" or "the Company")

Trading Update

TyraTech, Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health, today provides an update on trading for the six month period ended 30 June 2009. The Company will announce its interim results on 16 September 2009. 

Product sales for the first half of 2009 continue to grow, supported particularly by the Company's first orders of insecticide by its new partner, Terminix. However, the Board anticipates that revenues and profits for the full year 2009 will be significantly below current market expectations. Cash balances are expected to be at or near market expectations at year end. The reduction in revenue projection ties to a reduced activity in certain low-margin business areas, and the difficulty in accurately forecasting the size and timing of new orders for the Company's major commercial businesses - notably its commercial partner Terminix and its Sustainable Solutions division - that are otherwise showing material sales growth. Directors' expectations of year end cash levels being near to, or at, current market expectations are due to improved working capital management and close operational management of expenses and have been arrived at, assuming revenue from contracts in hand or which are close to completion.

While additional contracts and orders are expected in 2009, the Company will communicate these developments to the market, when they are accurately known.

TyraTech's main commercial programs are progressing well. The development project with Kraft Foods is on track for 2009 and no reductions in revenue are expected. TyraTech's partnership with Terminix has developed ahead of schedule and has already led to two major product orders, the first of which has been delivered and the second of which is scheduled for the next few weeks. Terminix's marketing of the SafeShield insecticide product is only in the initial stages, and though underway, accurate forecasting of new orders is difficult until some experience is gained.

TyraTech's other partnerships with Arysta and TyraChem are continuing to develop well and the Company will provide guidance to the market as significant changes in revenue expectations occur.

One line of projected business revenue for 2009 was expected though the Company's commercial partner in India. Based on difficulties in getting payments and slow market development of what has been a low margin opportunity, TyraTech will no longer continue this commercial activity, and has included this decision in its revised guidance.

TyraTech's Sustainable Solutions business is progressing well with a significant amount of interest in the division's products. Revenues for the year are largely to come from the sales of its WasteSolver and SolidSolver equipment to dairy farms for effective waste management. Sales have been adversely affected largely due to the price of milk in the USA, which has dropped by 44% since January 2008, and dairy farmers are cautious about taking on new financial commitments. This situation has resulted in a reduction in the projected revenue for 2009. However, the level and rate of completed purchase contracts has increased in late Q2 2009, and the business is expected to show revenue growth through 2009 as new installations are commissioned. TyraTech has engaged advisors to explore bringing in a new strategic investor to further accelerate its rate of growth.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said: "In 2009, TyraTech has successfully demonstrated a transition from the development state to a growing commercial company with several product lines and market adoption. Revenues are on the rise led by our relationships with Terminix and Kraft Foods, along with the progress in our Sustainable Solutions Division. Our multiple paths of revenue business model is beginning to clearly be demonstrated.

"While the business operations have progressed well, we are cautious about how quickly our markets will expand and we are therefore carefully controlling our costs and working capital investments. We remain positive that we can execute our business plan and strategy and that there is potential for high gross margins on products and additional material payments from partnering and licensing deals. We believe that we will be able to evidence this progress through announcements during the rest of 2009 and we will carefully expand expectations as the business grows into 2010."

For further information please contact:

TyraTech Inc.
 
Douglas Armstrong Ph.D., Chief Executive Officer
+1 (321) 409 7723
Keith Bigsby, Chief Financial Officer
+1 (321) 409 7714
www.tyratech.com
 
Nomura Code Securities
 
Charles Walker / Clare Terlouw
+44 (0)20 7776 1200
www.nomuracode.com
 
Buchanan Communications
 
Mary-Jane Elliott / Lisa Baderoon
+44 (0)20 7466 5000
/ Catherine Breen / Stasa Filiplic
 
www.buchanan.uk.com
 

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

###

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPUUUAMUPBUCW
Date   Source Headline
27th Apr 20129:59 amRNSAward of Share Options
20th Apr 20122:46 pmRNSHolding(s) in Company
18th Apr 20121:03 pmRNSHolding(s) in Company
10th Apr 20123:00 pmRNSDirector Dealing, Issue of Shares and AR Amendment
30th Mar 20122:36 pmRNSDirectorate Change
15th Mar 20125:00 pmRNSHolding(s) in Company
7th Mar 20122:04 pmRNSHolding(s) in Company
6th Mar 20127:00 amRNSIssue of Equity
5th Mar 20125:26 pmRNSHolding(s) in Company
2nd Mar 201211:42 amRNSHolding(s) in Company
27th Feb 20125:15 pmRNSResult of Special Meeting
17th Feb 201212:43 pmRNSAppointment of Joint Broker
14th Feb 20121:00 pmRNSProposed Placing and Subscription
2nd Feb 20129:00 amRNSTrading Update
1st Feb 20127:00 amRNSChange of Adviser
11th Jan 20127:00 amRNSTrading Update
7th Dec 201110:44 amRNSReplacement: Migration of Shares
7th Dec 20117:00 amRNSMigration of Shares and Block Listing Review
26th Oct 20117:00 amRNSCourt ruling in favour of TyraTech
25th Oct 20117:00 amRNSAdvisor appointed to seek Product Sale Partners
19th Oct 20117:00 amRNSTyraTech appoints a Head of European Operations
7th Oct 20117:00 amRNSMigration of shares
23rd Aug 20117:00 amRNSGerman Registrations for Three Aerosol Products
17th Aug 20117:00 amRNSDirector/PDMR Shareholding
11th Aug 20113:07 pmRNSDirector/PDMR Shareholding
11th Aug 20117:08 amRNSInterim Results
27th Jul 20115:38 pmRNSResult of AGM
30th Jun 20117:00 amRNSPosting of Annual Report and Accounts 2010
24th Jun 201112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20115:55 pmRNSDirector/PDMR Shareholding
10th Jun 20115:46 pmRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSPreliminary Results
7th Jun 20116:08 pmRNSDirector/PDMR Shareholding
1st Jun 20118:00 amRNSCourt ruling in favour of TyraTech
27th May 20114:56 pmRNSDirectorate Change
1st Mar 20118:00 amRNSShare migration to unrestricted trading line
25th Feb 20118:00 amRNSBlock listing application
4th Jan 20119:01 amRNSHolding(s) in Company
29th Dec 20102:23 pmRNSHolding(s) in Company
21st Dec 20102:26 pmRNSMajor Shareholdings
21st Dec 20109:00 amRNSIssue of Equity
30th Nov 20108:16 amRNSHolding(s) in Company
12th Nov 20103:31 pmRNSDirector Remuneration & Treasury Share Readmission
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
21st Oct 20103:22 pmRNSAward of Share Options
21st Oct 20103:22 pmRNSAward of Share Options
20th Oct 20107:00 amRNSSupply Agreement Signed With Terminix
6th Oct 20107:00 amRNSSignificant reorder from Terminix
4th Oct 20107:00 amRNSCorporate Broker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.